---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-126211"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:49:01.319961+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CV Sciences FY2025 revenue down 12% to $13.8M; adjusted EBITDA loss narrows to $0.3M

## Summary
- Revenue $13.8M for FY2025 vs $15.7M in 2024, a 12.2% decline on lower volume and regulatory headwinds.
- Gross margin improved to 49.0% from 45.6%; operating loss reduced to $0.5M from $2.2M.
- Adjusted EBITDA loss was $0.3M, improved from $0.8M in 2024; Q4 2025 delivered positive adjusted EBITDA of $0.1M.
- Cash balance $0.3M at year-end; completed debt restructuring in Q1 2026 to strengthen financial position.
- Launched 39 new products since Jan 2023; new products contributed 39% of FY2025 net revenue.

## SEC filing metadata
- accession: 0001193125-26-126211
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000119312526126211/0001193125-26-126211-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000119312526126211/cvsi-20260326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-126211
- JSON: https://secwatch.observer/filing/0001193125-26-126211.json
- Plain text: https://secwatch.observer/filing/0001193125-26-126211.txt

## Key facts
- Earnings Releases
  CV Sciences, Inc. reported the year and quarter ended December 31, 2025 results: revenue $13.8 million.
  - Period: the year and quarter ended December 31, 2025
  - Revenue: $13.8 million
  - Result: reported results
  source text: its financial results for the year and quarter ended December 31, 2025. Fiscal 2025, Fourth Quarter 2025 and Recent Financial and Operating Highlights • Generated revenue of $13.8 million for fiscal 2025 compared to $15.7 million for 2024; Revenue of $3.3 million for the fourth quarter 2025 compared to $3.9 million for the fourth quarter 2024 and $3.3 million for
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526126211/0001193125-26-126211-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.